NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | DQF-COSY | 2.0 mM VEGF heparin-binding domain; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
2 | 2D NOESY | 2.0 mM VEGF heparin-binding domain; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
3 | 3D_15N-separated_NOESY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
4 | HNHA | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
5 | DQF-COSY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 99.9% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
6 | 2D NOESY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 99.9% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
7 | 2D 15N IPAP-HSQC | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
8 | 2D 15N IPAP HSQC | 0.6 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride; 0.02% sodium azide | 4:1:0.2 ditridecanoyl-phosphatidylcholine/dihexanoyl-phosphatidylcholine/cetyltrimethylammonium bromide, 5% w/v total lipid in 90% H2O, 10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |